Insurance executives are facing a quiet but costly drag on performance: billions tied up in non-admitted assets (equipment, technology infrastructure, tenant improvements) that serve critical functions yet provide no regulatory capital benefit.
Non-admitted assets likely exceed $500 billion today. A large portion of this capital is trapped in operational investments deemed non-admitted under statutory accounting rules. These are assets that cannot be counted toward regulatory capital—despite their essential role in business operations.
It’s a hidden inefficiency with material consequences.
A Balance Sheet Blind Spot
Unlike corporations that report under GAAP, insurers follow Statutory Accounting Principles (SAP), a conservative framework that excludes illiquid assets from capital calculations. Furniture, fixtures, servers, software, even custom office buildouts: none of these count. And yet, every insurer needs them.
The result? Capital locked in assets that can’t be leveraged, impairing financial flexibility and competitive positioning.
Major insurers like UnitedHealth, Cigna, and Elevance manage vast portfolios of operational infrastructure. These assets are mission-critical—but under SAP, they’re invisible when it comes to solvency metrics. The more these investments grow, the more capital insurers must hold elsewhere to offset them.
Sale-Leaseback: A Strategic Unlock
Enter the sale-leaseback. These transactions, common in the $1.3 trillion equipment finance market, allow insurers to convert non-admitted assets into cash providing a clean regulatory capital gain.
From a regulator’s perspective, the insurer improves liquidity. From a rating agency’s view, there’s no leverage spike. And from a shareholder’s lens, it’s a rare opportunity to improve return on equity without raising risk.
Why It Matters Now
Low investment yields, rising technology spend, and expanding compliance requirements are pressuring margins across the industry. Meanwhile, competitive forces—insurtech disruption, M&A activity, and ESG scrutiny—demand more agile capital allocation.
Sale-leasebacks offer a practical lever for insurance CFOs and treasurers looking to rebalance. A $30 million tech refresh doesn’t need to drain capital ratios. A $20 million buildout for a regional claims center doesn’t need to sit inert on the books. By monetizing these investments, insurers can redirect capital to growth, reserves, or shareholder return.
A Case in Point
Consider a regional insurer with $2 billion in premiums and $50 million in non-admitted assets. Converting those assets into cash via sale-leaseback could boost its admitted asset base by 12.5%, all while maintaining full use of the equipment and infrastructure. It’s transformative.
Why Dolfin
At Dolfin, we specialize in structuring sale-leaseback solutions tailored to insurance companies. We did just that with Applied Underwriters (Read the case study here).
Our leases are long-term, unsecured, and designed to meet both operational and compliance objectives. We’ve built our platform around the specific needs of insurance companies.
With regulators recognizing sale-leasebacks as liquidity enhancements rather than new liabilities, and insurers increasingly pressured to unlock capital, the moment for this strategy is now.
Bottom Line: The non-admitted asset problem is large, growing, and solvable. For insurance companies looking to compete in a capital-intensive, compliance-heavy world, sale-leasebacks offer a strategic advantage.
To explore how Dolfin can help your team unlock capital without sacrificing control, message us or visit dolfinpartners.com.
